Sumitomo Pharma America is focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. We are looking for a Manager, Corporate Financial Planning & Analysis. Apply today or share it with a friend looking to join a great company. #Sumitomolife Come join us: https://bit.ly/45LYxnp
Sumitomo Pharma America, Inc.’s Post
More Relevant Posts
-
From computation to clinic: Hear from GAIN CEO Matthias Alder about how our #AI-powered platform can help accelerate drug discovery, to reduce the time from screening and molecule identification to drug from years to months. ➡ You can catch the entire chat with Zacks Investment Research analyst John Vandermosten at https://lnkd.in/gyiPYEZt #drugdiscovery #drugdevelopment #biotech #pharma #neurodegeneration #neurology #computationalbiology
-
The NEW YEAR is a great time to consider the NEXT BEST STEP in your career! We are representing several compelling Clinical Development Opportunities for experienced industry physicians, including a highly visible and impactful strategic role with a financially sound, mid-size company dedicated to help people living with complex and difficult-to-treat neurological and psychiatric disorders. If you are curious about this role or others I am representing, let's talk. #neuroscience #pharmaceutical #biotechnology #clinicalresearch #clinicaldevelopment #neurology #clinicaltrials #phase2 #phase3 #executivedirector #medicaldirector #biopharmaceutical
-
-
Researcher | Biostatistician |Academic medical writer|Msc Public Health |Epidemiologist | Clinical pharmacist
https://lnkd.in/d3qdCXjq Check our recent research paper in European Journal of Clinical Pharmacology Always pleased to have a great team. Ibrahim Serag Khalid Sarhan Mohamed Abouzid #research #neurology #pharmacology
-
#Immunity and #Inflammation is on the up and up. #Neurology is the surprise second place, and #oncology only tied for third, with #obesity, as execs and investors weigh in on where innovation is headed, in BioCentury Inc.'s survey. How does #PrecisionMedicine fare? What will be the next gains in obesity? And why does amyloid barely get on the radar for future gains in #alzheimersdisease?
-
NfL biomarkers are revolutionizing neurology diagnostics. Recent validation across 17 centers worldwide set Simoa® NfL as the gold standard for blood-based biomarker measurement. Learn more in our ebook. 📚 #SimoaNfL #Neurology #Healthcare
Diagnostic Value of Biomarkers in Neurology: Validation and Reference Values
go.quanterix.com
-
Pharma D - Partner in Life Sciences. Biotech-Pharmaceutical Executive Global Commercial Leader. Multiple launch experience, Go-to Market Strategy , Ability to drive growth. lnnovative and Biosimilars
🧬Addressing Unmet Needs in Orphan Neurological Diseases and Pipeline Selection of Promising Drugs There are still huge unmet Needs in Neurology rare diseases. Some Diseases such as ALS are devastating and the need for new treatments are vital. Genchrome has developped comprehensive pipeline of potential assets to acquire. 🔗Key Features: - Detailed Data: Extensive information on drugs in development including commercial potential - Market Insights: Up-to-date data on emerging trends and unmet needs in neurology. - Pharma Partners: Specifically curated to aid in the identification of potential pharma partners. - Due Diligence: Genchrome can help with commercial and market access due diligence to assist in the evaluation and acquisition process. Discover Genchrome's IP Database for Neurology Rare Diseases. Any plans in neurology rare disease? Feel free to contact us at: contact@genchrome.com #raredisease #neurology #IPdatabase #biotech #pharma #licensing #duediligence
-
AstraZeneca's #rarediseases subsidiary has entered into a collaboration that will make use of Verge Genomics' #artificialintelligence (AI)-enabled #drugdiscovery platform to identify new targets for rare #neurodegenerative and #neuromuscular illnesses. https://lnkd.in/ec2zb-vW #AI #AstraZeneca #licensing #neurology #pharma #VergeGenomics
AstraZeneca inks AI pact with Verge centred on rare neuro disorders
-
Preclinical studies validate the potential of #ApTOLL developed by aptaTargets to reduce inflammation and regenerate myelin in models of #MultipleSclerosis. The results of the research have been published in the "British Journal of Pharmacology": https://lnkd.in/diKtrHXF #DrugDevelopment #aptamers #cytoprotection #neurology
-
-
NfL biomarkers are revolutionizing neurology diagnostics. Recent validation across 17 centers worldwide set Simoa® NfL as the gold standard for blood-based biomarker measurement. Learn more in our ebook. 📚 #SimoaNfL #Neurology #Healthcare
Diagnostic Value of Biomarkers in Neurology: Validation and Reference Values
go.quanterix.com
-
R&D, Drug Development & Medical Affairs, Market Access Global Clinical Studies and Product Marketing Lifecycle Management across the Globe, Regulatory Advisor
Overcoming Barriers to Effective Treatment and Enrollment in Clinical Trials for Black and Underserved Patients With Multiple Myeloma A topic to discuss #clinicaltrials #biotech #pharmaceutical #oncology #diabetes #neuroscience #rarediseases
General Dentist at Simply Beautiful Smiles
1wI’ve shared this! Is there a recruiter I can share to follow up on this?